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ABSTRACT For certain cell types, the cross-linking of bivalent cell surface receptors by multivalent ligands is an
important biochemical step in the transmission of information across the cell's membrane to its interior. The formation
of cell surface receptor-ligand aggregates has been shown to "turn on" and "turn off' particular cell responses. It has
been hypothesized that very large aggregates generate signals that small aggregates cannot. This hypothesis has not
been rigorously tested as yet, in part because of a lack of quantitative information about aggregate sizes. Here we
develop a general equilibrium theory for the clustering of bivalent receptors by trivalent ligands. In addition to
predicting the concentrations of receptor-ligand aggregates of all possible sizes, we show that a range of ligand
concentrations exists at which extremely large aggregates, i.e., superaggregates, form on the cell surface. The formation
of a superaggregate corresponds to a sol-gel phase transition, and we study this transition in some detail. For the
biologically interesting case of histamine release by basophils, we show, using realistic parameter values, that such
transitions should occur when the cells are from highly allergic individuals. We prescribe in detail experimental
conditions under which such transitions should occur. These conditions can be used as a guide to test whether or not
large aggregates provide signals to cells that small aggregates do not.
INTRODUCTION
The aggregation of receptors on cell surfaces triggers
significant physiological responses in a variety of biological
systems. For example, the clustering of the epidermal
growth factor (EGF) receptor on human epidermoid carci-
noma cells leads to the aggregation of these receptors in
coated pits and the induction of DNA synthesis (1).
Anti-EGF receptor antibodies (2) which are capable of
cross-linking EGF receptors, initiate many of the same
biological events that EGF does. Similarly, bivalent anti-
bodies raised against the insulin receptor mimic many of
the effects of insulin (3,4). Aggregation of the gonadotro-
pin releasing hormone receptor into microaggregates, pos-
sible dimers, leads to the release of pituitary luteinizing
hormone from pituitary cultures (5,6).
One of the best worked out examples of the role of
receptor aggregation in initiating cellular responses is the
immunoglobulin E- (IgE-) mediated activation and desen-
sitization of basophils and mast cells. In the presence of
calcium, clustering of cell surface IgE antibodies, or the Fc,
receptors that IgE binds to, triggers mast cells and baso-
phils to release histamine (7-9). Simply forming IgE
dimers is sufficient to trigger both histamine release (10)
and specific desensitization (11). The binding of mono-
meric ligands to IgE triggers neither release nor desensiti-
zation (12,13). As expected, trimers of IgE also trigger
release, but, surprisingly, the trimer release signal appears
to be qualitatively different than that of the dimer (14,15).
Whether very large aggregates can generate signals that
small aggregates cannot is unknown. It is still an open
question, for example, whether the nonspecific desensitiza-
tion of basophils (16) is triggered by large aggregates of
IgE or by large numbers of cross-linked IgE, independent
of the size of the aggregate in which they occur (17).
When basophils and mast cells are exposed to a bivalent
ligand, the only surface aggregates that can form are linear
and circular chains of IgE and ligand. If the ligand's
valence is three or greater, networks of IgE and ligand can
be built up, and, at least for some parameter values, both
aggregates and "superaggregates" can form on the baso-
phil surface. These superaggregates, which correspond to
the gel phase in a system capable of undergoing a sol-gel
transition, can span a large fraction of the cell surface.
Although the valence of almost all naturally occurring
allergens (ligands capable of triggering an allergic reaction
culminating in histamine release from basophils and mast
cells) is unknown, the expectation is that many are highly
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multivalent. Thus, it is worth while investigating if, for the
parameters that characterize the basophils, sol-gel-like
phase transitions can occur.
If the receptor and ligand each has a valence of at least
two and either the ligand or receptor has a valence of three
or greater, the possibility exists that gelation can occur on
the cell surface. Here we consider the simplest case where
gel-like states can form. We present an equilibrium theory
for the binding of a trivalent ligand to a bivalent cell
surface receptor such as IgE. We derive conditions for the
onset of the sol-gel transition and discuss under what
experimental situations this transition can be observed on
basophils. From our results for this simple model system
we discuss possible ways to test if superaggregates are
capable of generating unique biological signals.
THEORY
We consider a dilute suspension of cells that have a
homogeneous population of bivalent receptors on their
surfaces. The medium surrounding the cells also contains
trivalent ligand at an equilibrium concentration C. The
ligand can bind to the bivalent receptors, but we assume
the concentration of cells is so dilute that ligands cannot
simultaneously bind to receptors on different cells. We
assume that there are XT receptors per cell and that during
the time it takes for equilibrium to be established XT
remains constant, e.g., both internalization or shedding of
receptors and insertion of newly synthesized or recycled
receptors into the membrane is negligible.
At equilibrium, we characterize a trivalent ligand bind-
ing to cellular receptors by three constants (see Fig. 1): K,
the intrinsic affinity, which describes the binding of a
single site on a ligand in solution to a single cell surface
receptor site; K,, the first cross-linking constant, which
describes the binding to a single receptor site of a site on a
Bivalent
receptor
* * 1
ligand that already has one of its sites bound to a receptor;
and K,,, the second cross-linking constant, which describes
the binding to a single receptor site of a site on a ligand that
already has two sites bound to two other receptors. We
assume that a ligand cannot have two of its sites bound
simultaneously to the two sites on a single receptor. To
present the theory it is useful to introduce the following
nondimensional parameters:
c = 3KC
a = 4KXXT
(la)
(Ib)
(Ic)A = KXXXT.
Linear Chains
Our procedure for characterizing the system is to enu-
merate and assign the correct statistical weight to all
possible receptor-ligand complexes. We begin by consider-
ing linear chains. In Fig. 2 all linear chains that begin and
end with a free receptor site are depicted. If we letX be the
equilibrium concentration of free receptors (both sites
unoccupied) on the cell surface, then, from Fig. 1 and Eqs.
la and 1 b, the equilibrium concentration of a complex
of two receptors cross-linked by a single ligand is
12KKXCX2 = aCX2/XT and the equilibrium concentration
of a linear chain of n receptors cross-linked by n - 1
ligands is (acX/XT)-''X. We now define certain quantities
referred to in statistical mechanics as partition functions.
A partition function is simply the sum of the concentra-
tions of all aggregates or of a subclass of all aggregates. For
example, we define Qf, the partition function for linear
chains with both ends free, as shown in Fig. 2, to be the sum
Qf(X) = X YEn- (acX/XT)' = X/(1 - acX/XT).
In general each end of a linear chain can be in one of two
states, free or bound. Taking this into account, Qo, the
Trivolent
3k+.A
k_ |
._1___1n y 2kXX+
2k xx-
K = k+/k_ , Kx = kx+ /kx- , Kxx=kxx+ /kxx_
FIGURE 1 The three classes of reactions that occur between a bivalent receptor and a trivalent ligand: the binding of a single site on the ligand
to a receptor site with equilibrium constant K, the first cross-linking step with equilibrium constant K,, and the second cross-linking step with
equilibrium constant K,,. In the figure we have assumed the linear chain is planted at its left end and growth only can occur at the right. The
statistical factors multiplying the rate constants indicate the number of ways each reaction can occur.
BIOPHYSICAL JOURNAL VOLUME 45 1984
4kx+
kx-~+Y
>4.
0 0 9
* * 0
* * 0
1110
Q-y++ ( +..
Qf - X + (CaX/XT)X+ (CLX/XT)2X +
FIGURE 2 The partition function for linear chains which both begin and
end with a free receptor site.
partition function for all linear chains becomes
QO(X) = (1 + C)2X/(1 - aCX/XT). (2)
We will work with the nondimensional partition functions
qf = Qf/XT and qo = QO/XT, and the nondimensional
receptor concentration x = X/XT. In terms of these quanti-
ties
qo(x) = (1 + c)2qf = (1 + c)2x/(l - acx). (3)
An important biological quantity is xpoly, the fraction of
receptors in aggregates, which we define as
xpoly= 1 -w,
where
w = (1 + c)2x. (5)
The quantity w is the fraction of receptors in un-cross-
linked states.
The nondimensional partition function for all linear
chains can now be expressed as
qo(w) = w/(1 -bw) (6)
where
a= IC/(l + C)2. (7)
Dembo and Goldstein (18) previously analyzed the
equilibrium binding of bivalent ligands to bivalent recep-
tors and obtained results identical in form to Eq. 6. The
only change is that for a bivalent ligand the statistical
weights that give the number of ways a ligand can bind to a
receptor are different, in particular c = 2KC and a =
2KXXT.
Branched Chains
To obtain the partition function, which includes both linear
chains and branched structures, we follow a procedure for
counting aggregates used by G-o in the theory of helix-coil
transitions (19) and Wiegel and Perelson in their study of
red cell aggregation (20). We shall only consider structures
that do not contain loops. In graph theory, such structures
are called trees. A subclass of trees that plays a central role
in our counting method is "planted plane trees" whose
nodes are of degree three or less. A planted tree is a tree
with one end, its root, distinguished from all other ends
(21). We begin our enumeration procedure at the planted
end of a tree. A planted plane tree is a planted tree that can
be drawn in the plane in such a way that no branches
intersect except at nodes (21). The degree of a node is the
number of branches incident with it (21). One can show by
direct construction that a way to count and assign the
correct statistical weight to molecular aggregates that
contain no loops is to first count and weight planted plane
trees and then to correct for the degeneracy that arises by
having chosen one particular end at which to begin the
counting. After we derive the partition function for
branched aggregates, we will show by example that we
have assigned precisely the same statistical weights as one
would have obtained by considering a sequence of chain
elongation and chain branching reactions that lead to the
final structure. Gordon and Temple (22) and Gordon and
Torkington (23) discuss in general the relationship
between tree counting and the statistical weights in a
partition function. In their discussion, they choose to map
molecular aggregates into trees differently than we do and
hence utilize a different tree counting procedure to obtain
statistical weights. Tutte (24) and Gordon and Torkington
(23) derive different methods of counting planted plane
trees that give results that are equivalent to the ones we
derive below. However, our method, in addition to counting
the number of planted plane trees, automatically assigns a
statistical weight to the tree and is thus more useful for our
purposes.
To begin our counting, we define a planted plane tree of
order 0 as a linear chain. We define a planted plane tree of
order 1 to be a linear chain or a planted plane tree with one
branch point (Fig. 3a). To obtain the partition function for
trees with one branch point we begin assigning statistical
weights at the root. All planted plane structures start with
a linear chain whose rooted end may be free or bound. This
initial chain contributes a term (1 + c)qf to the partition
function. This chain terminates in a receptor with one free
site. To form a branch point, a ligand must first bind to this
site. This binding contributes a term 3KC to the partition
function. A receptor must now bind to each of the two
remaining free ligand sites. The binding of a receptor to the
first ligand site contributes a term 4KXX to the partition
function, while the binding of the second receptor contrib-
utes a term KXXX (see Fig. 1). Thus, for a linear chain with
a branch point leading to two receptors one obtains the
nondimensional partition function (1 + c)qf cafx2. To
count all planted plane trees with a single branch point we
a I v /
b
FIGURE 3 The planted plane trees of (a) order 1 and (b) order 2.
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need to allow the two arms that bifurcate from the linear
planted chain to be any length. Formally, we do this by
replacing x with qf(l + c) in the partition function.
Consequently, ql, the partition function for a tree of order
1 is given by q1 = qo + (1 + c)qf caf3 qf2(1 + C)2. Using Eq.
3 this simplifies to
q, = qo(1 + yq2), (8)
where we have introduced the branching parameter -y,
ccaf
ly
l+ C)3 (9)
We now define a planted plane tree of order k to be
either a linear chain or a planted plane tree that begins
with a linear chain and then bifurcates into two planted
plane trees each of order k - 1. By analogy with the
arguments given above, the partition function for a planted
plane tree of order k is
qk = qO(l + yqk 1). (10)
So, for example, a planted plane tree of order 2 is either a
linear chain or a linear chain that bifurcates into two
planted plane trees of order 1. From Eq. 10 we find that the
partition function
q2 = qO(l + yq 2).I 1
When the expression for q1, Eq. 8, is substituted into Eq.
11, the expression for q2 becomes
q2 = qo +yq3 + 2y2q5+'A3q7. (12)
From the picture of planted plane trees of order 2 shown in
Fig. 3 b, one sees that such trees may have any of five
possible structures, with each structure contributing one
term to the right side of Eq. 12.
As the index k is increased, planted plane trees of higher
and higher complexity are generated. In the limit as k -
cc, all possible planted plane trees are generated. We define
qp, the partition function for all planted plane trees, by
qp = rim qk-
k-X
From Eq. 10 we find qp must satisfy the equation qp = qo
(1 + yq2). Of the two solutions only one approaches qo as
-y 0. This solution, which is the one of interest, is given
by
qp1 - (1 - 4q)'o2 (13)
q= 2-yqo
To obtain q, the partition function for branched molecu-
lar structures, we must correct qp for certain degeneracies.
First, when we counted all linear chains we ignored the fact
that there are two possible choices for the root, the left or
right end. In our subsequent counting of planted plane
trees, we always assumed the tree began with an initial
linear chain, i.e., its "trunk." This choice placed no
constraint on possible tree structures, since we allowed the
trunk to be as small as a single ligand or a single receptor.
Because one can choose either the left or right end of the
trunk chain as a possible root we multiply qp by a factor of
2 to correct for the degeneracy in this choice. Second, a
given molecular structure planted at any of its ends
corresponds to the same molecular structure. We correct
for this degeneracy by dividing the statistical weight for a
planted plane tree with m branch points by m + 2, the
number of free ends. To determine the statistical weight of
a planted plane tree with m branch points, we note that if
we expand qp in a power series in y, the coefficient of y' is
the desired statistical weight. To obtain q, we could, in the
power series for 2qp, replace tm by ym/(m + 2). This
means that
__- ('y2q) = qp
2y dy
where qp is given by Eq. 13. Solving this differential
equation, we find
(14)
As a check we note that in the limit of zero branching (y
0) q reduces to qo. As a further check, we compare below
the concentration of aggregates of a particular size as
predicted from q; the prediction was obtained by the usual
chemical procedures.
Concentration of Aggregates Containing n
Receptors
From the partition function q, we can obtain an expression
for the concentration of ligand-receptor aggregates of
different sizes and shapes (i.e., with different degrees of
branching). Let w% be the nondimensional concentration of
aggregates containing n receptors. The previously intro-
duced variable w, the fraction of receptors in un-cross-
linked states, is w,. From the definition of qo [Eq. 6], we
note that w% is composed of a weighting factor q, multiplied
by w', i.e.,
. co
q = Z qwn - E wn.
n-I n-I
(l5a)
From Eqs. 14 and 6, we obtain the leading terms in this
expansion:
q(w) = w + 5w2 + 1/3(352 + 2y)W3 + (63 + 2'y5)W4
+ (54 + 4752 + y2)W5 + I/3(365 + 20,y3 + 15y2y)w6
+ (56 + 1iOY64 + 157252 + 2'y3)W7
+ (67 + 14,yb + 358263 + 14Y36)W8... (l5b)
It is easy to see where each term that contributes to q,
comes from. In Fig. 4 we illustrate this for n = 5. The
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FIGURE 4 The statistical weights of aggregates with five receptors as constructed directly from the reactions agree with those predicted by
Eq. 1 5b. The weighting factor qs in Eq. 1 5b is a sum of three statistical weights corresponding to the three types of aggregates five receptors
can form: aggregates with two, one, or no branch points. We show how to obtain these weights from the law of mass action, starting from the
known statistical weights for linear chains (Fig. 2). We show only aggregates whose ends are free. To obtain the statistical weight for all
aggregates involving five receptors, i.e., each end being either free or bound to a ligand, we must multiply each statistical weight by (1 + c)'
where e equals the number of ends. When this is done we find that q5 (64 + 4y62 + y2)W5.
example shown in Fig. 4 also demonstrates that our
tree-counting procedure gives rise to the usual statistical
weights as derived directly from chemistry.
We can find an analytic expression for the general term
in the expansion of q as follows. Let wn,M be the nondimen-
sional concentration of aggregates containing n receptors
and having m branch points (i.e., m + 2 ends). Then q can
be expressed as
q = q,,.mw = Wn,m. (16a)
n,m n,ml
Using techniques discussed by Wiegel and Perelson (20),
one can show that
26 (m 1 )( ) (w6n
wnm= (m + l)(m + 2) *(1b
Comparing Eqs. 1 5a and 16a one finds
En =26b Z(21n Im (y/62)m
M m (m +1)(m +2)
(17)
Unfortunately, a closed form expression for this summa-
tion cannot be obtained. (The term [']/[m + 1] is a
Catalan number [25] and the sum over m in Eq. 17 when
T = 62, seems to be a new generalization of the Motzkin
number [25]. This is not surprising since the Motzkin
numbers determine the number of planted plane trees with
n branches [26].)
Conservation Laws
The fraction of aggregates containing n receptors, w", is
expressed in Eq. 17 in terms of w, the fraction of receptors
in un-cross-linked states. To find w we note that the total
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number of receptors on the surface is constant. Thus w
must obey the following conservation law:
Oq
1 = nw= w
n- I Olw
tion law, extraneous roots have been introduced. In fact, if
one takes Eq. 19 and changes the term - 2(1 _ U) 1/2
to + 2(1 - U)1t2, so the equation reads
(18)
Using Eqs. 6 and 14, we write the conservation law in the
following form
1 = 12 -U(w) - 2[1 - U(w)] /2}, (19)
'ywU(w)
where
U(w) 4'yqo = 4yw2/(l -bw)2. (20)
Note that if U(w) is ever > 1, Eq. 19 breaks down, i.e., there
are no longer real solutions for w. As we shall see, the
critical case, U(w) = 1, will indicate the onset of a phase
transition, and, hence, U(w) will play an important role in
our theory.
Rewriting Eq. 19 with only [1- U(w)]1/2 on the right
side, squaring the resulting equation, and substituting in
Eq. 20 transforms Eq. 19 into
16y2w3[y2w3 + (2-y -62)w2 + (1 + 26)w - 1] = 0. (21)
From Eq. 9 'y : 0 as long as c # 0. Further w = 0 only
when all receptors are cross-linked, but such an equilib-
rium state can not be attained with finite cross-linking
constants. Hence we assume yw : 0 and reduce Eq. 21 to
the cubic
y2W + (2y- 62)w2 + (1 + 26)w - 1 = 0. (22)
Because Eq. 22 was derived by squaring the conserva-
2.0 , ....nl ' """1 h 111
1.0 \_ _ _
0
1Q-4 g02 c* 10 c: 102
cs 3KC
FIGURE 5 With a = 32, j8 = 8, and r. = 1, the cubic Eq. 22 was solved for
w. For each value of c there was only one real root. U(w) was formed
according to Eq. 20 and substituted into Eq. 19, the conservation law, or
Eq. 23. The right-hand sides of Eq. 19 ( ) and Eq. 23 (---) are plotted.
Note that w found by solving the cubic (Eq. 22) only satisfies the
conservation law for c < c* and c > c*. In the region c* < c < c*, w
satisfies the pseudoconservation law, Eq. 23.
1 = 12 - U(w) + 2[1 - U(w)]'121YwU(w) (23)
and then operates on it in a manner analogous to the
conservation law, one again derives Eq. 22. Real roots of
Eq. 22 may therefore correspond to a solution of either Eq.
19 or Eq. 23. This is shown explicitly in Fig. 5 for a
particular choice of y and 6. For each value of c there is
only one real root of Eq. 22. Substituting this value of w
into Eq. 19, one finds the conservation law is only satisfied
for c < c* or c > c*, where c* and c* are positive
concentrations whose values are determined below. We
also show below that in the region c* < c < c* (for which
this procedure does not yield a value of w satisfying the
conservation law), the system has undergone a phase
transition and we predict that an infinite-sized aggregate, a
gel, coexists with finite-sized aggregates, the sol.
Moments of the Aggregate Size
Distribution
At any external ligand concentration, one finds that on the
cell surface there is a distribution of receptor-ligand aggre-
gate sizes. Here we characterize that distribution by the
number of receptors in aggregates. Let MO, Ml, and M2 be
the zeroth, first, and second moment of the aggregate size
distribution, where size is measured in terms of the number
of receptors per aggregate. Then
MO-= W = q,
n-I
M=- fWp = W-,
n-I Olw
M2 -- E = Wa
(24a)
(24b)
(24c)
The zeroth moment is the total number of finite-sized
aggregates divided by the total number of receptors, XT.
The first moment is the total number of receptors in
finite-sized aggregates divided by XT. Thus, it all aggre-
gates are finite, Ml = 1, as indicated by the conservation
law, Eq. 18. We define the value of a summation running
from n = 1 ton = ooas the limit ofN - ooof finitesums
ranging from n = 1 to n = N. If an infinite-sized aggregate,
or gel, appears, then M, will be < 1 and 1 - Ml will
correspond to the fraction of receptors in the gel phase.
During the course of a polymerization reaction, a point
may be reached at which the probability of having an
infinite-sized aggregate changes from zero to a positive
value. This point is called the gel point. At the gel point, Ml
is still one, but because large aggregates have become
prevalent, one finds M2 - oc. Although we know of no
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general proof that M2 must become unbounded at the gel
point, this in fact is the case in all well-studied examples.
The second moment, M2, is related to a common mea-
sure of aggregate sizes in polymer chemistry, the weight
average degree of polymerization,
DP, = M2/Mi. (25)
At the gel point, M2, and therefore DP,, -- 00. Because
DP, can be easily measured (e.g., by light scattering), the
divergence of DP, has become the practical criteria for
having reached the gel point. From Eqs. 18-20 and 24c,
one finds that
M2= -1 - 2 {1 + [1- (1 U)-U/2]/ywW. (26)(1-6w)
Generation of Superaggregates
When U = 1 we see from Eqs. 25 and 26 that DP, becomes
unbounded, indicating the presence of infinite-sized aggre-
gates, i.e., a gel. In a finite system, such as a cell surface,
infinite-sized aggregates can not appear, but one finds that
a single super-large aggregate forms, which is substantially
bigger than any other aggregate (27-29). We shall show
that the condition U = 1 can be met for biologically
realistic values of C, y, and 6 in the well-studied system of
IgE-mediated histamine release from human basophils.
Hence we predict that sol-gel transformations can occur on
cell surfaces in systems involving the binding of trivalent
ligands to bivalent receptors.
No Superaggregates Form in Systems
Containing Only Linear Aggregates
Before studying the occurrence of cell surface sol-gel
transformations, we review the situation when only linear
aggregates can occur (18). In this case y = 0 and hence
from Eq. 20, U = 0 if qo(w) is finite. When y = 0, q = qo,
and the conservation law reduces to
0(10 wI = Wc-= (- (27)
Eq. 27 is a quadratic equation for w that has the explicit
solution,
1 + 26- /1 + 46
262
(28)
(The solution with the positive square root is not physical
since w goes to infinity rather than one as the ligand
concentration, and therefore 6 -a 0.) For all values of 6, i.e.,
0 < 6 .< 0, the solution for w, given by Eq. 28, satisfies the
conservation law, Eq. 27, and has the properties that w - 1
and bw < 1. This means that qo(w) = w/(1 -bw) is real,
nonnegative, and finite for all nonnegative values of 6. Thus
U = 0, and linear chains never show a phase transition.
For linear chains, one can explicitly calculate w,,, the
moments of the aggregate size distribution, and DP,:
I I + 26 11 + 46]n61 26 1
w 1 + 26 - r11+ 46
I -bw 6(11+46-1)
w
(1 _6W)2
M2 = DPw = (- w)3 -6bw
1 + 46 - /1 + 46
j11+ 46- 1
(29a)
(29b)
(29c)
where the expressions on the right were obtained by
replacing w by its value in Eq. 28. Because Ml = 1, DPw =
M2.
When y > 0 Branched Superaggregates
Can Form
When cell surface aggregates can be branched structures,
the situation changes dramatically. As shown in Fig. 6 for
parameter values that characterize the cross-linking of IgE
on the surface of a basophil, U = 1 in a biologically relevant
range of ligand concentrations. In what follows, we shall
first show that there are two values of c, c*, and c, for
which U = 1 for given values of the parameters y and 6.
Then we shall argue that for ligand concentrations between
c* and c* a phase-transition occurs with an infinite-sized
aggregate (a gel) coexisting with finite-sized aggregates
(the sol). It is for concentrations between c* and c* that
the conservation law, Eq. 19, breaks down.
0 1 IlJ' slfll I I H I ll IIIIfil{lIII.maiiiI amasaimal l,a,,d
10-4 lo-2 100 102
c - 3KC
FIGURE 6 A plot of U(w) vs. c for r. - 1 and S - 8. For each value of c,
Eq. 22 was solved for wand U(w) calculated from Eq. 20. Note that U - 1
at c* and c*.
-
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To determine the critical values of c that delinate the
two-phase region, we set U = 1. From Eq. 19, the conserva-
tion law, we observe that when U= 1,
w = w-=/y*, (30)
where we use the superscript * to denote a "critical value,"
i.e., the value assumed when U = 1. Because w is the
fraction of receptors in monomer, w* must be <1 or,
equivalently,
aY* > 1.(31)
Evaluating U at w*, we see from Eq. 20 that only for
parameters y and a that satisfy
41*
1= (Y* - 6*)2 (32)
can U = 1. Because y and 6 are functions of c, Eq. 32
implies that only at particular values of c, designated c*,
can U = 1. Substituting Eqs. 7 and 9 for oy and 6 and using
the definitions in Eq. 1, Eq. 32 can be rewritten as
I + I + 1)c* (33)
Thus c$ is determined as the solution to the following cubic
equation
(r. - 1)C3
+ (3rx-2 + 2fl)c2 + (3r.- 1 + 2# -_2)c + r = 0, (34)
where
exists only for f:- 4. When ,3 = 4, we have from Eq. 37 that
C c 1/3. This value of c* obeys Eq. 36. As j3 is
increased above 4, for example, by increasing the concen-
tration of receptors on the cell surface, c* and c*' separate
and the concentration range in which a gel phase exists
increases (see Fig. 7). For , > 4 we can show by tedious
algebra that c* and c* obey Eq. 36.
For ligand concentrations corresponding to values of c
between c* and c*, the sol and gel phase coexist. To make
predictions about the compositions of these two phases
(e.g., the fraction of receptors in sol) the fraction of
receptors in gel, the distributions of aggregate sizes in sol,
we must introduce an equation to replace the conservation
law, Eq. 19, since it is no longer obeyed in the sol-gel
region. We now examine one obvious choice for this
equation, U(w) = 1.
U(w) = 1: An Equation of State in the
Sol-Gel Region
In the sol-gel region, c* < c < c*; a fraction f. of the
receptors will be in the sol phase and a fraction 1 - f. will
be in the gel phase. Because there are XT receptors per
cell
XS =fSXT, (38)
where X, is the concentration of receptors in the sol phase.
We define, for c* < c < c*,
a. = 4KXS = afs9
As = K,,K, = Of,
(39a)
(39b)
r, = KXX/KX. (35) and from Eqs. 7 and 9
In addition to being a solution to Eq. 34, c* must obey the
inequality Eq. 31 which, for r. > 0, can be written in the
form
4'c*> rx(l +c*). (36)
Numerical simulations indicate that there are at most two
real nonnegative values of c* which solve Eq. 34 and obey
this inequality. When rx = 1 we can explicitly find these
two values of c*.
x
I-
'C
Special Case: Symmetric Trivalent Ligand
(rx= 1)
When rx = 1, the first and second cross-linking constants
are equal, i.e.,
KX = KXX. For this case Eq. 34 becomes quadratic in c with
solutions
(40a)bs=6fs,
,Y =fs'y. (40b)
We assume that in the sol-gel region the description that
102(37)*6a- 2(1+ ,B) ± [,B3( 4)]1/2c± = 2(l + 2,B)
For values of , < 4, there are no real solutions to Eq. 37.
Thus, when r. = 1, the possibility of a phase transition
c-3KC
FIGURE 7 Phase diagram plotted for r. - 1. The solid line is the locus of
c* and c* values for different values of P. Note that when P > 4 sol and gel
phases coexist for the region of c values between c! and c*.
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we have developed still applies, but only to those receptors
in the sol phase. The conservation law, which now holds
only for these receptors, has the same form as Eq. 19, but
with y and a replaced by
-y. and b5, i.e.,
1
1 =
-Y. {2- U(w,) -2 [I - U(wj}. (41)W.U(W.)
We designate w, as the fraction of receptors in the sol that
are not in aggregates. To calculate w,, we need to know Xs
or equivalentlyf,, i.e., we need an additional equation that
describes the coexistence of sol and gel. The equation that
we choose is
(42)
We have used the condition U(w) = 1 coupled with the
conservation law to obtain c* and c*. When U(w) = 1, M2
and all higher moments blow up indicating that the size of
some aggregate has become unbounded. We now assume
that U(w) = 1 holds throughout the sol-gel region, not
simply the end points. Elsewhere we show that Eq. 42,
when applied to the polycondensation of trivalent monom-
ers is equivalent to Stockmayer's condition (30) for
describing the sol-gel region (Perelson and Goldstein, in
preparation).
Because U(w,) = 1 and the conservation law, Eq. 41,
both hold, y, and 6, satisfy Eq. 32. Substituting b5 and -y, for
5* and * in Eq. 32 and solving forf,, we find
( + c) [r1/2(l + 1/c)'12 + 1]. (43)
We can predict all the properties of the sol because when
U(w,) = 1, w, = 1 /'yv. Thus, for c* _ c < c* one finds from
Eqs. 40b, 30, and 9 that
w = (1 + c)3/(cf,a20). (44)
Now, for example, from Eq. 17 we can calculate the
concentration of any size aggregate in the sol-gel region by
replacing y, 6, and w by %y, 5,, and w, = I /-y,.
We now study some of the characteristics of the sol-gel
region. Eq. 43 predicts that f, is inversely proportional to
, = K,X,XKT, and therefore inversely proportional to XT.
Thus, for a fixed concentration between c* and c*, increas-
ing XT should decreasef, in such a way that XTfS remains
constant. Thus, cells with large numbers of receptors
should have a more prominent gel phase with a smaller
fraction of their receptors remaining in the sol. For XT
fixed,f, = 1 at c = c*. As c is increasedf, first decreases to
a minimum and then increases until]' = 1 again at c = c*
(see Fig. 8).
To determine the dimensionless concentration between
c* and c* at which f, is a minimum, cmin, we differentiate
Eq. 43 and set dfl/dc = 0. We find that Cmin is a solution to
the equation
0 = -1 + 3c + 4(1 I/rX)c3, (45)
1.0I-r
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z
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FIGURE 8 A plot of the fraction of receptors in the sol,f,, vs. log c for r, =
1 and , = 8. The minimum in the curve occurs atf. = 0.5 and c,,,,, = 1/3.
which can be expressed in the following form (31):
Cmin = sinh(k/3)/sinh 1 (46a)
where
sinh 0 = (1/r.-I )1/2. (46b)
Because c 3KC, we see from Eq. 46 that the ligand
concentration, C5,,n, at whichf, is a minimum depends only
on the ligand-receptor single-site equilibrium constant K
and r, = KXX/KX, the parameter that measures the asymme-
try in the ligand's ability to branch. Thus, for example, C n,
does not depend on the cell surface receptor concentration
nor on any properties of the cells themselves.
For the special case r, = 1, Cmin = '/3 (C,,,ni = 1/9 K), and
fs = 4/(3. (Recall that for r, = 1, a phase transition can only
occur for ,B 2 4.) If r, < 1, the minimum is shifted to lower
concentrations, but if the asymmetry in cross-linking con-
stants is not too large the shift will be quite small, for
example for r, = 0.5, Cmin = 0.298.
APPLICATION TO HISTAMINE RELEASE
FROM BASOPHILS
Basophils are leucocytes that play a central role in allergic
reactions. Stored in granules within these cells are potent
mediators of anaphylaxis such as histamine and serotonin,
while on the surface of basophils are Fc, receptors which
bind IgE with high affinity (32,33). When IgE specific for
a known antigen is bound to these receptors the basophil is
said to be sensitized. Cross-linking of surface IgE in the
presence of calcium can trigger sensitized basophils to
degranulate (7,10-12).
When the ligand used for cross-linking is a simple
bivalent antigen that rapidly equilibrates, the equilibrium
distribution of cross-linked IgE determines what signals
are generated by the ligand. Theory shows that cross-
linking will be a maximum, i.e., the maximum number of
IgE antibodies will be in aggregates, when the bivalent
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ligand concentration C = 1/2 K (18). Further, the cross-
linking curve, a plot of xpoly vs. log C, will be symmetric
about the maximum concentration. When the number of
surface IgE antibodies per basophil is relatively small
(<5,000), the histamine release curve for these cells, i.e.,
the percentage of the total histamine contained in the cells
that is released when the cells are exposed to a ligand
concentration C vs. log C, has the same general shape as
the cross-linking curve. For example, the maximum of both
curves occurs at C = 1/2 K. Thus, by determining the
concentration at which maximum histamine release is
obtained with a bivalent antigen, one can determine the
single site ligand-IgE equilibrium constant (34).
When there are large amounts of specific IgE on the
basophil surface, the histamine release curve no longer
follows the cross-linking curve. In the concentration range
where cross-links are still rising, histamine release
decreases (35). Large numbers of cross-links or possibly
large aggregates appear to turn the cell off (desensitize)
rather than on (16,17,36).
Parameters Characterizing Aggregate
Formation on Basophils
The equilibrium constant, K, for the binding of a single IgE
receptor site to a binding site on an antigen can vary over
many orders of magnitude, typically 104 M'1 - 109 M-l.
The binding of a simple synthetic bivalent penicillin hap-
ten, (BPO)2, to human anti-penicillin IgE has been exten-
sively studied (12,34,36,37,39). Although K depends on
the particular antiserum from which the IgE is obtained,
usually K 107 M'- (34). Further, for the human sera
studied, the binding of (BPO)2 to surface IgE equilibrates
in seconds (37).
There are now available a number of monoclonal IgE
antibodies. A murine monoclonal IgE that is being widely
used in the study of histamine release binds DNP-lysine at
370C with K = 7.1 x 107M-' (38).
Cross-linking constants on cell surfaces have not been
directly measured. The cross-linking constant, KX, for the
bridging of two IgE molecules by (BPO)2, has been
estimated to be - 8 x 10-10 cm2/molecule from fitting a
model to histamine release data (39). This agrees with
theoretical calculations of K., which estimate that KX =
10-9 cm2/molecule for bivalent haptens between 30 and
40 A in length and with equilibrium constants of I07 M-'
(18).
The parameter rx KXX/Kx is a measure of the asymmetry
in the ligand's ability to cause chain branching relative to
its ability to cause chain elongation. We expect that in
general rx < 1. Before the first cross-linking step, the ligand
is anchored at only one site, whereas before the second
cross-linking step, it is anchored at two sites. Thus, we
expect Kx > Kx, i.e., we expect it is easier for a free site on
a ligand with one site bound to randomly search and find a
free IgE site than for a free site on a ligand with two sites
bound. In the latter case the free sites' motions are more
severely restricted.
The number of IgE molecules per basophil on cells from
allergic individuals range from -5 x 104-5 x 105 (40).
However, the amount of this IgE that is specific for a
particular antigen is usually much less. For example, 5 x
1025- x 104 IgE molecules per basophil specific for antigen
E, the major ragweed antigen, were found on basophils
from a group of hay fever patients (41). In our theory, XT
refers to the number of specific IgE molecules per baso-
phil.
By using basophils with free Fcf receptors (usually from
nonallergic donors) and incubating them with IgE against
a known antigen, the amount of specific IgE on the cell
surface can be controlled (42). Using this passive sensitiza-
tion technique, MacGlashan and Lichtenstein (36) varied
the number of anti-BPO IgE per basophil from 8 x 102 _
1.4 x 104 molecules. Much higher numbers of specific IgE
per cell are difficult to achieve with human basophils from
nonallergic donors, since these cells tend to have -<5 x 104
Fc, receptors, with a fraction already filled with IgE. Rat
basophilic leukemia cells, however, have -5 x i05 free Fc,
receptors (43) and higher values of XT may be obtainable
using these cells.
We can now estimate the range of values of the parame-
ters a and ,B. Recall a = 4KXXT. For Kx = 10- cm2 and
XT = 104 specific IgE/basophil, and using the measured
surface area of a basophil, 4.7 x 10-6 Cm2 (37), so that
XT = 2.1 x I09 specific IgE/cm2, we find a = 8.5. Thus for
102- 105 receptors/cell, 0.085 < a s 85. The parameter
(3= KXX.XT r%a/4. Thus, for the same parameters, 0.021r" _
(3 < 21rr. In Table I we summarize the ranges of the
parameters we have discussed.
Can Superaggregates Form on Basophils?
We have shown (see Eq. 37) that for r,, = 1, superaggre-
gates can only form if (3 2 4, or equivalently if a 2 16. In
general, however, we expect r,, < 1. In Fig. 9, we show the
coexistence curves, the values of c* and c* as a function of
a or, equivalently, XT, for particular values of r4 between
0.1 and 1.0. From Fig. 9, which was based on numerical
studies, we conclude that for all values of rx s 1, (3 2 4 to
have superaggregate formation. Further, we conclude that
for a fixed value of a, decreasing r4 favors the formation of
aggregates with long linear chains over highly branched
structures. This can be overcome, and highly branched
aggregates can be obtained by increasing a-or, equivalent-
ly, XT, the amount of specific IgE on the cell surface. When
r4 = 1, to obtain a phase transition, a 2 16, while when r. =
0.1, a 2 85.1. Because for a typical small ligand with K =
107 M-', we estimate that a values as high as 85 can occur
on basophil surfaces (Table I), we predict that superaggre-
gates can form when highly sensitized basophils (XT> 2 x
104 receptors/cell) are exposed to the appropriate concen-
tration of trivalent ligand.
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c le .;
c is 3KC
042
102 FIGURE 10 Cross-linking curves, i.e., the fraction of receptors cross-
linked, xp,y, vs. log c, for r, - I and fi = 1, 2, and 4.
FIGURE 9 The locus of points dividing the sol region from the sol-gel
coexistence region for different values of a and r,. The solid lines indicate
the values of c* and c* for each value of a and r4.
Theoretical Cross-Linking Curves
In studying histamine release from basophils, it is useful to
compare measured histamine release curves with predicted
cross-linking curves. As we pointed out, for bivalent
ligands, the cross-linking curve is a symmetric bell-shaped
curve with its maximum at C = 1/2K, or, equivalently,
c = 1. For trivalent ligands, when no superaggregates from,
i.e., < 4, the cross-linking curves look similar to those
obtained with a bivalent ligand. The maximum of the
cross-linking curve however, is no longer at c = 1, but is
now between c = 0.5 and 1.0. (A proof of this is given in the
Appendix.) The curve appears to be symmetric about its
maximum, but we have not proven this is so.
In Fig. 10, we show three cross-linking curves for r1 = 1,
and (t = 1, 2, and 4. As is increased, for example by
increasing the number of specific IgE molecules per cell,
the cross-linking curve increases. This is because for any
ligand concentration, increasing XT increases the cross-
linking and branching parameters y and 6 and therefore
the fraction of IgE molecules that are in aggregates.
For the sol phase, the fraction of receptors in aggregates,
xpoiy = 1 - w. In Fig. 10, xply was calculated from this
formula by solving Eq. 22 for w. When the sol and gel
phases coexist there are contributions from both phases to
xpo,y. All the receptors in the gel phase and (1 - wj)
receptors in the sol phase are cross-linked, so that
xply = (1 -Sf) + (1 -W.M = 1 - wf1. (47)
From Eqs. 43 and 44, therefore,
poy =1 -ac[l + r"2(l +C/c)22] c* cc c* (48)
By differentiating xpo,y and setting dxpolyldc = 0, we find
for r = 1 that Eq. 48 is maximum when c = (7 + lii/16
0.70. Thus in the sol-gel region xpoly is a maximum at c
0.70 provided r1 and > 4.3. (For < 4.3, c 0.70 is
not between c* and c*.)
In Fig. 11, r I= 1 and = 8, so there is a range of
concentrations where sol and gel coexist. From Eq. 37, we
TABLE I
TYPICAL PARAMETER VALUES FOR SENSITIZED BASOPHILS
Parameter Symbol Typical range Units
Single site equilibrium binding constant K 104-109 M
First equilibrium cross-linking constant K. 10-1ilO0-7 cm2
Second equilibrium cross-linking constant K.1 Kxx ' KS cm2
Cross-linking asymmetry parameter r=- KXX/Kx 0-1
Specific IgE concentration XT 1 x 102 - 5 x I s IgE/cell
Dimensionless ligand concentration c = 3KC 10-4-104
Dimensionless first cross-linking constant a - 4KXXT 10 - 4 x 102*
Dimensionless second cross-linking constant KXXT - r1a/4 10-4_l02*
*The range for a and,was computed for K. c 10-9cm2.
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FIGURE 11 The fraction of receptors cross-linked, xpwy, vs. log c, for r, =
1 and ,B = 8. For c < 0.022 and c > 2.68 there is only one phase (sol) and
all cross-linked receptors are in finite sized aggregates. For 0.022 < c <
2.68 there are two phases and xp,,y is the sum of the fraction of receptors
that are in finite aggregates (sol) plus the fraction of receptors that are in
infinite aggregates (gel).
determine that this range corresponds to 0.022 .< c*
2.68. For the ligand concentration range that gives rise to
sol-gel coexistance, we calculated xpoly from Eq. 47, while
outside this range we calculated x.1Y as before, from Eq. 47
with f, = 1 and w, = w. Note that the maximum in xpoly
occurs at c = 0.68 as predicted.
Even though at c = c* = 0.022 and c = c* = 2.68 there is
a phase transition, the cross-linking curve in Fig. 11 is a
smooth function of c. Thus, any biological signal that is a
function only of the number of receptors in aggregates will
also be a smooth function of the ligand concentration and
will not "detect" the phase transition. However, if a
biological signal exists that is triggered by very large
aggregates, then there should be a dramatic change in this
signal as c is increased, say from a value slightly less than
c* to a value slightly greater than c*.
CONCLUSIONS
When trivalent ligands are exposed to bivalent cell surface
receptors, the possibility arises that superaggregates, i.e.,
very large ligand-receptor aggregates that span major
portions of the cell surface, can form. We have shown that
for a small, trivalent ligand with a single-site equilibrium
binding constant K = 10-7 M- , superaggregates can form,
provided there are a sufficient number (-2 x 104 or more)
of specific IgE molecules (bivalent receptors) on the cell
surface. Irrespective of the receptor density, at very low
and high ligand concentrations there will be no superaggre-
gate formation. When the amount of specific IgE is high
enough, superaggregate formation will occur in a ligand
concentration range centered about C = 1/9K, an easily
obtainable ligand concentration.
Because some experiments have already been performed
in which highly sensitized basophils have been exposed to
highly multivalent ligands (36, 44, 45), the question arises
as to why no dramatic change in the histamine-releasing
properties of these cells have been reported. One possible
explanation is that histamine release in the systems studied
depends strongly on the number of IgE molecules in
aggregates, but only weakly or not at all on the size of the
aggregate. Our theory shows that the cross-linking curve
for all IgE concentrations is a smooth function of the ligand
concentration. When the ligand concentration is raised to
the critical value where superaggregates form, some IgE
molecules that are in small aggregates become part of the
superaggregate, but there is no abrupt change in the total
number of IgE molecules that are cross-linked. Only if a
biological signal that depends on very large aggregates
exists, will a dramatic change be seen. (Nonspecific desen-
sitization of basophils has been suggested as a candidate
for such a signal [46], but it is still an open question.) An
alternative explanation is that for the ligands used, the
kinetics of superaggregate formation is so slow that hista-
mine release is over before any large aggregates form. For
example, the kinetics of large aggregate formation was
observed to be slow compared with histamine release when
basophils were exposed to fluorescein-conjugated heteroge-
neous anti-IgE (47). Because the anti-IgE was heteroge-
neous, the receptor (IgE) had an effective valence greater
than 2 for the ligand (anti-IgE). The possibility of slow
aggregate formation can be eliminated by allowing binding
to occur over a long time period at 40C. At this tempera-
ture histamine release and desensitization are suppressed.
The cells can then be warmed, and histamine release
measured.
Another difficulty in observing a sol-gel transition by
studying basophils arises because in general the basophil
cell surface IgE concentration is heterogeneous. If dif-
ferent cells in the basophil population being studied have
different amounts of cell surface IgE, the ligand concentra-
tion range over which superaggregates form will differ
from cell to cell. This heterogeneity will therefore tend to
blur the effects of the phase transition.
The equilibrium theory we have presented has certain
limitations. We have neglected loop formation and only
considered aggregates composed of branched treelike
structures. Including loops in the theory is a difficult,
unsolved problem. It has been included in the theory of
bivalent receptor cross-linking by bivalent ligands (18,48)
and only approached in approximate ways in polymer
chemistry for branched aggregates (49,50). For solution-
phase, polycondensation reactions, such as antibody-
antigen reactions, it is generally believed that loop forma-
tion is not a significant process until the gel point is
reached, unless the system is very dilute (51-53). This is
because a free site on a molecule can either react intermo-
lecularly with a free site on another molecule or intramole-
cularly with a free site on the same molecule. In the pre-gel
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state, the number of free sites on any given molecule is
generally small compared with the total number of free
sites available in solution. Once a superaggregate forms,
loop formation may become significant because the num-
ber of free sites on a superaggregate can be an appreciable
fraction of all the free sites in the system (51, 52). On a cell
surface the possibility of intramolecular reactions is greatly
increased, first, because, unlike as in the solution case, the
number of free sites available for intermolecular reaction is
always limited and less than the total number of free sites
on the cell surface. Second, a free site on an aggregate can
find another free site on the same molecule by undergoing
a random walk with a much higher probability in two
dimensions than in three dimensions. For example, for a
linear chain of n links, the probability of one end finding
the other end goes as n-' in two dimensions, and as n-312 in
three dimensions (18, 53). We know of no published data
addressing the question of loop formation in cell surface
aggregates. However, if loop formation is important on cell
surfaces, its effect will be to make it more difficult to
achieve superaggregate formation. This is because loops
reduce the number of free sites available for increasing the
size of any aggregate. Much higher values than 2 x 104
specific IgE per cell will be needed to overcome loop
formation and cause superaggregate formation. Thus it is
possible for loop formation to prevent the occurrence of
superaggregates on basophils.
We have also assumed that a single ligand cannot bind
to both sites on a single receptor. It is straightforward to
take such monogomous bivalent attachments into account.
An additional equilibrium constant must be introduced
and an additional state added to Qo, Eq. 2, as was done for
the bivalent ligand case (18).
A very useful tool in the study of histamine release from
basophils is a monovalent ligand that competes for the
same receptor sites as the cross-linking agents being used
to trigger release. Adding monovalent ligand always
decreases the concentration of cross-links and therefore
monovalent ligand can be used to manipulate in a known
way the cross-linking curve and the concentration range
over which superaggregates can form. If both trivalent
ligand and monovalent ligand with an equilibrium constant
Km and concentration Cm are present, our theory can be
modified to include monovalent ligand simply by replacing
(1 +c)by(I +c+cm),wherecm=KmCm.
The theory we have presented provides a new method for
finding the critical conditions (i.e., ligand concentration,
values of a, f,, and K) at which a cell surface sol-gel phase
transition occurs. For the special case, r. = 1, Macken and
Perelson (54), using branching processes, have derived the
gelation condition. Both methods give the same result. The
branching process method also gives for r. = 1, the
concentration of receptor-ligand aggregates of all possible
sizes (54). While the branching process method in princi-
ple can be generalized to cases in which rx < 1, in practice it
is not yet clear whether explicit solutions can be found.
DeLisi (55) and Perelson (56) have previously studied the
binding of multivalent ligands to cell surface receptors.
Their work complements ours in that they predicted the
total concentration of ligand bound to the surface, and the
concentration off-valent ligand bound to the surface at i =
1, 2, .. .fsites, quantities not predicted here. Perelson (56)
also considered the inhibition of cross-linking by mono-
valent hapten. DeLisi (55) identified the sol-gel phase
transition, but neither his nor Perelson's model is valid in
the coexistence region. Perelson (56) noted that in certain
parameter ranges, his model gave spurious results, but
failed to identify this parameter regime as one in which a
phase transition occurred.
Although we have concentrated on the basophil, our
results are clearly applicable to other cell and model
systems. Recently Peacock and Barisas (57), while
studying the binding of multivalent ligands to bivalent
immunoglobulin on liposomes, obtained results indicating
the occurrence of a sol-gel phase transition.
APPENDIX
Here we show that c,,., the dimensionless concentration at which xp.y is a
maximum, is between 0.5 and 1.0, when S < 4, i.e., when there is no gel
region. From the sum rule, Eq. 18, and the expansion for q, Eq. 1 5b, we
have that
xpoly= 1 - w = 26w2 + (362 + 2,y)w3
+ 4(65 + 2-y)w4 + ... (Al)
Using a prime to indicate a derivative with respect to c we have that when
c = cn,., x' = w' = 0. From Eq. Al therefore, when c =c,-
0= 26'w2 + 2(365' + y)W3
+ 4(3626 + 2,y'b + 2Ty5')w4 + ... (A2)
Because w is nonzero (for any ligand concentration there are always a
finite number of receptors not in aggregates) the right side of Eq. A2 can
only be zero if either all the coefficients of each w" term are simulta-
neously zero or some coefficients are negative and some positive. We show
below that all the coefficients are not simultaneously zero. Therefore
some coefficients must differ in sign. For this to occur 6' and -' must be of
different signs. Because
a'=a(1 -c)/(l + c), (A3)
and
(A4)
this can only occur when 1 > c > 1/2.
To find the numerical value of c. when ,8 < 4, we note that in general
w is given by the cubic Eq. 22. As we noted above, at c - c., x.,=y w' =
0. We find by differentiating Eq. 22 that 2ry2w2j, + (2'y' - 25')wmiun +
1 + 25' = 0, where ww,,, is the value of w at c = c,,. . This equation can be
solved for w,w,, as a function of a, ,f, and c, since 'y and a are themselves
functions of these variables. Substituting w,,,, into Eq. 22, one obtains a
nonlinear equation for c, as a function of a and ,, that can be solved
numerically.
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